2588:HKEXBOC Aviation Limited Analysis
Data as of 2026-07-28 - not real-time
HK$78.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
BOC Aviation trades at HK$78, comfortably above its 20‑day (HK$78.08), 50‑day (HK$77.39) and 200‑day (HK$77.31) moving averages, signaling a bullish trend. The MACD has turned bullish and the RSI sits near the midpoint at 51, suggesting limited downside pressure while the price still respects a solid support zone around HK$74.2. The stock offers an attractive 4.5% dividend yield with a modest 36.7% payout, and its forward PE of 7.2 is well below the industry average of 31.3, indicating relative value. However, the DCF fair value of HK$28 is far beneath the market price, reflecting a potential overvaluation on a cash‑flow basis, compounded by a high debt‑to‑equity ratio of over 250% and negative free cash flow. The recent announcement of a sizeable order for up to 220 Pratt & Whitney engines, capable of powering 110 A320neo aircraft, underscores growth prospects for the fleet.
Overall, the stock sits in a bullish technical environment with strong dividend appeal, but investors must weigh the leverage and cash‑flow gap against the upside implied by analyst targets (median HK$93) and the extreme‑greed market sentiment.
Overall, the stock sits in a bullish technical environment with strong dividend appeal, but investors must weigh the leverage and cash‑flow gap against the upside implied by analyst targets (median HK$93) and the extreme‑greed market sentiment.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price above all major SMAs and bullish MACD crossover
- Strong dividend yield with manageable payout ratio
- Support level at HK$74.2 providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst median target price of HK$93 implies ~20% upside
- Order for 220 Pratt & Whitney engines expands fleet capacity
- Forward PE of 7.2 vs industry PE of 31.3 indicates valuation headroom
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage (debt‑to‑equity >250%) and negative free cash flow
- Geographic concentration in China exposing regulatory and macro risk
- Sustainable dividend and long‑term lease contracts underpin cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin34.28%
P/E Ratio8.8
ROE11.92%
ROA3.33%
Debt/Equity251.35
P/B Ratio1.0
Op. Cash FlowHK$2.9B
Free Cash FlowHK$-2275338240
Industry P/E31.3
Technical Analysis
TrendBullish
RSI51.1
SupportHK$74.20
ResistanceHK$82.65
MA 20HK$78.08
MA 50HK$77.39
MA 200HK$77.31
MACDBullish
VolumeDecreasing
Fear & Greed Index88.91
Valuation
Fair ValueHK$28.25
Target PriceHK$93.72
Upside/Downside20.15%
GradeUndervalued
TypeBlend
Dividend Yield4.52%
Risk Assessment
Beta0.40
Volatility25.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.